Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Davies Pharmaceuticals LLC has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct examiner, Erin Asa Kim, and is situated within a distinct art unit. This individual is the busiest examiner for the company, overseeing the pending workload.
The company's current prosecution activity is focused on the matter within Medical Devices & Mechanical Engineering. This pending office action is being reviewed by Erin Asa Kim, which centralizes the legal risk and strategy for this portfolio. This official is the sole person managing the legal matters currently active.
The involvement of a distinct art unit suggests that the pending office action relates to a specific technical niche within the broader field. Because there is only the pending office action, the company's immediate patent goals are tied to the decisions of the examiner. The current review will determine the outcome for the prosecution effort in this specific case.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, ERIN ASA | 1 | 69.0% | +34.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18422214 | Graduated Dose Dispenser And Applicator | KIM, ERIN ASA | — |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18422214 | Graduated Dose Dispenser And Applicator | KIM, ERIN ASA | 3781 | §103 | Final Rejection | — | Pending | Jan 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDavies Pharmaceuticals LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Erin Asa Kim has the most, with 1 of Davies Pharmaceuticals LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
